Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.14.5901

Influence of Service Characteristics on High Priority Performance Indicators and Standards in the BreastScreen Australia Program  

Roder, David Murray (School of Population Health, University of South Australia)
Ward, Gail Heather (Department of Health and Human Services)
Farshid, Gelareh (SA Pathology and Royal Adelaide Hospital)
Gill, Peter Grantley (Royal Adelaide Hospital Breast Endocrine Surgical Unit.)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.14, 2014 , pp. 5901-5908 More about this Journal
Abstract
Background: Data from BreastScreen Australia Screening and Assessment Services (SAS) for 2002-2010 were analysed to determine whether some SAS characteristics were more conducive that others to high screening performance, as indicated by high priority performance indicators and standards. Materials And Methods: Indicators investigated related to: numbers of benign open biopsies, screen-detected invasive cancers, and interval cancers, and wait times between screening and assessment. Multivariate Poisson regression was undertaken using as candidate predictors of performance, SAS size (screening volume), urban or rural location, year of screening, accreditation status, and percentages of clients from culturally and linguistically diverse backgrounds, rural and remote areas, and socio-economically disadvantaged areas. Results: Performance standards for benign biopsies and invasive cancer detection were uniformly met irrespective of SAS location and size. The interval cancer standard was also met, except in 2003 when the 95% confidence interval of the rate still incorporated the national standard. Performance indicators improved over time for: benign open biopsy for second or subsequent screening rounds; rates of invasive breast cancer detection for second or subsequent screening rounds; and rates of small cancer detection. No differences were found over time in interval cancer rates. Interval cancer rates did not differ between non-metropolitan and metropolitan SAS, although state-wide SAS had lower rates. The standard for wait time between screening and assessment (being assessed ${\leq}28$ days) was mostly unmet and this applied in particular to SAS with high percentages of culturally and linguistically diverse women in their screening populations. Conclusions: Gains in performance were observed, and all performance standards were met irrespective of SAS characteristics, except wait times to assessment. Additional descriptive data should be collected on SAS characteristics, and their associations with favourable screening performance, as these may be important when deciding on SAS design
Keywords
BreastScreen; meeting accreditation standards; system characteristics;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Australian Institute of Health and Welfare (2012). BreastScreen Australia monitoring report 2009-2010. Cancer series no. 72. Cat. no. CAN 68. Canberra, AIHW.
2 Australian Institute of Health and Welfare (2010). Breastscreen Australia monitoring report 2006-2007 and 2007-2008. Cancer series no. 55. Cat no. CAN 51. Canberra, AIHW.
3 Autier P, Boniol M, Gavin A, et al (2011). Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ [Epub ahead of print].
4 BreastScreen Australia (2004). BreastScreen Australia decision tool. To assist with accreditation decision-making against the National Accreditation Standards. Endorsed by the National Advisory Committee to BreastScreen Australia. Canberra, Commonwealth of Australia.
5 BreastScreen Australia (2005). National accreditation handbook. Endorsed by the Australian Screening Advisory Committee. Canberra, Commonwealth of Australia.
6 BreastScreen Australia Evaluation report (2009). BreastScreen Australia evaluation - Evaluation final report. Screening Monograph No. 1/2009. Canberra, Commonwealth of Australia.
7 Broeders M, Moss S, Nystrom L, et al (2012). The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screening, 19, 14-25.
8 Broeders M, Nystrom L, Njor S, et al (2012). The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen, 19, 14-25.
9 Burton RC, Bell RJ, Thiagarajah G, et al (2012). Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat, 131, 949-55.   DOI
10 Department of Health and Ageing (2009). BreastScreen Australia Evaluation. Screening Monograph No.4/2009. Mortality (ecological) study. Australian Government Department of Health and Ageing, Canberra.
11 Gabe R, Duffy SW (2005). Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncology ESMO, 16, 153-62.
12 Glasziou P, Houssami N (2011). The evidence base for breast cancer screening. Prev Med, 53, 100-2.   DOI   ScienceOn
13 Kalager M, Zelen M, Langmark F, et al (2010). Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med, 363, 1203-10.   DOI
14 Kang MH, Park EC, Choi KS, et al (2013). The national cancer screening program for breast cancer in the republic of Korea: is it cost-effective? Asian Pac J Cancer Prev, 14, 2059-65.   과학기술학회마을   DOI   ScienceOn
15 Marmot MG, Altman D, Cameron D, et al (2013). The benefits andhanns of breast cancer screening: an independent review. Brit J Cancer [Epub ahead of print].
16 Moss SM, Nystrom L, Jonsson H, et al (2012). The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen, 19, 26-32.
17 McKeon S (2012). Strategic Review of Health and Medical Research in Australia. Consultation paper summary. Issues and proposed recommendations. Canberra, Australian Government Department of Health.
18 Morrell S, Barratt A, Irwig L, et al (2010). Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control, 21, 275-82.   DOI
19 Morrell S, Taylor R, Roder D, et al (2012). Mammography screening and breast cancer mortality in Australia: an aggregate cohort study. J Med Screen, 19, 26-34.
20 Nickson C, Mason KE, English DR, et al (2012). Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev, 21, 1479-88.   DOI
21 Njor S, Nystrom L, Moss S, et al (2012). Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen, 19, 33-41.   DOI   ScienceOn
22 Olsen O, Gotzsche PC (2001). Screening for breast cancer with mammography. The Cochrane Library, 4, 1877.
23 Otto SJ, Fracheboud J, Verbeek AL, et al (2012). Mammography screening and risk of breast cancer death: a population- based case-control study. Cancer Epidemiol Biomarkers Prev, 21, 66-73.
24 Paap E, Holland R, den Heeten GJ, et al (2010). A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes and Control, 21, 1569-73.   DOI
25 StataCorp (2013). STATA Statistical Software. Release 12. College Station, Texas, StataCorp LP
26 Paci E (2012). Summary of the evidence of breast cancer service outcome in Europe and first estimate of the benefit and harm balance sheet. J Med Screen, 19, 5-13.   DOI
27 Roder D, Houssami N, Farshid G, et al (2008). Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res and Treat, 108, 409-16.   DOI
28 Roder D, Webster F, Zorbas H, et al (2012). Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia. Asian Pac J Cancer Prev, 12, 147-55.   과학기술학회마을   DOI   ScienceOn
29 Taylor R, Morrell S, Estoesta J, et al (2004). Mammography screening and breast cancer mortality in New South Wales, Australia. Cancer Causes and Control, 15, 543-50.   DOI
30 World Health Organization, (IARC) International agency for research on cancer (2002). IARC handbooks of cancer prevention Vol. 7: Breast Cancer Screening. Lyon, IARC Press.
31 Yoo KB, Kwon JA, Cho E, et al (2013). Is mammography for breast cancer screening cost-effective in both Western and Asian countries?: results of a systematic review. Asian Pac J Cancer Prev, 14, 4141-9.   과학기술학회마을   DOI   ScienceOn
32 National Quality Management Committee (2004). BreastScreen Data Dictionary Standards. Canberra, National Quality Management Committee.
33 Gahlinger PM, Abramson JH (1995). Computer programs for epidemiologic analysis. Stone Mountain, Georgia, USD Inc.